BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Caris Diagnostics Expands Personalized Medicine Services to Include BRAF Mutational Analysis for Colon Cancer Patients


5/28/2009 9:19:34 AM

IRVING, Texas and PHOENIX, May 28, 2009 (GLOBE NEWSWIRE) -- Caris Diagnostics (Caris Dx), a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and hematopathology, announced today that it has expanded its Target GI Colon(sm) tumor testing panel for colorectal cancer (CRC) patients to include BRAF mutation analysis. With the expansion, Target GI Colon(sm) is now one of the most comprehensive colorectal testing panels available, leading to better, more effective therapeutic choices for colon cancer patients.

Read at GlobeNewswire

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES